Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of PSS World Medical, Inc. (“PSS World Medical” or the “Company”) (NASDAQ: PSSI) for potential breaches of fiduciary duties in connection with their conduct related to the sale of the Company to McKesson Corporation (NYSE: MCK) in an all-cash deal valued at approximately $2.1 billion. Under the terms of the proposed transaction, PSS World Medical’s stockholders will receive $29 in cash for each share of PSS World Medical common stock they own. Request more information now by clicking here: www.faruqilaw.com/ PSSI.There is no cost or obligation to you. The investigation focuses on whether PSS World Medical’s Board of Directors breached their fiduciary duties to the Company’s stockholders by failing to conduct an adequate and fair sales process prior to agreeing to this proposed transaction, whether and by how much this proposed transaction undervalues the Company to the detriment of PSS World Medical’s shareholders. Faruqi & Faruqi, LLP is a national law firm which represents investors and individuals in class action litigation. The firm is focused on providing exemplary legal services in complex litigation in the areas of securities, shareholder, antitrust and consumer litigation, throughout all phases of litigation. The firm has an experienced trial team which has achieved significant victories on behalf of the firm’s clients. If you own common stock in PSS World Medical and wish to obtain additional information and protect your investments free of charge, please visit us at www.faruqilaw.com/PSSI or contact Juan E. Monteverde, Esq. either via e-mail at email@example.com or by telephone at (877) 247-4292 or (212) 983-9330. Attorney Advertising. (C) 2012 Faruqi & Faruqi, LLP. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We are happy to discuss your particular case.
PSS World Medical (Nasdaq:PSSI) hit a new 52-week high Thursday as it is currently trading at $28.98, above its previous 52-week high of $28.97 with 511,249 shares traded as of 2:54 p.m. ET. Average volume has been 1.5 million shares over the past 30 days.
PSS World Medical (Nasdaq:PSSI) hit a new 52-week high Thursday as it is currently trading at $28.97, above its previous 52-week high of $28.95 with 1.3 million shares traded as of 11 a.m. ET. Average volume has been 1.6 million shares over the past 30 days.
PSS World Medical (Nasdaq:PSSI) hit a new 52-week high Wednesday as it is currently trading at $28.79, above its previous 52-week high of $28.75 with 892,390 shares traded as of 2:40 p.m. ET. Average volume has been 1.6 million shares over the past 30 days.